You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Albemarle reported Q3 net sales of $1.6 billion and adjusted EBITDA of $646 million, raised specialties outlook to $350 to $375 million, and cut 2026 capital expenditures to $300 million to $350 million from approximately $500 million.
Albemarle reported third-quarter 2026 net sales of $1.6 billion, up 19%, and adjusted EBITDA of $646 million, up 186%. It cut its full-year 2026 capital expenditure forecast to $300-$350 million and raised Specialties adjusted EBITDA outlook to $350-$375 million.
Albemarle Corporation entered a $1.5 billion unsecured revolving credit facility on October 29, 2026, maturing October 29, 2031, terminated its 2022 Credit Agreement, and adopted bylaws allowing shareholders owning at least 20% of outstanding shares to request a special meeting.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
TL;DR. Albemarle reported strong third-quarter growth and margin expansion, generated $1.5 billion of year-to-date operating cash flow and $1.2 billion of free cash flow, raised its Specialties outlook and reduced 2026 capital spending, and expects Energy Storage sales-volume growth in 2027. The main risks are lower sequential Energy Storage results, higher-cost inventory, and $70-$90 million of unmitigated Middle East-related cost escalation.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted diluted income per share attributable to common shareholders non-GAAP | $3.75 | Q2 2026 | — |
| Adjusted EBITDA non-GAAP | $1.52B | Six Months Ended June 30, 2026 | — |
| Consolidated Leverage Ratio non-GAAP | 0.5 | Twelve Months Ended June 30, 2026 | — |
| Consolidated Windfield-Adjusted EBITDA non-GAAP | $2.03B | Twelve Months Ended June 30, 2026 | — |
| Consolidated Windfield-Adjusted Funded Net Debt non-GAAP | $996.13M | Twelve Months Ended June 30, 2026 | — |
| Energy Storage Adjusted EBITDA non-GAAP | $723.5M | Q2 2026 | — |
| Energy Storage Avg. Realized Price | $19.53 | Q2 2026 | — |
| Energy Storage Sales Volume | 65 | Q2 2026 | — |
| Free cash flow non-GAAP | $638M | Q2 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net cash provided by operating activities 710M
-71.73M Capital expenditures
= Free cash flow 638.27M
|
|||
| Operating cash flow conversion non-GAAP | 83% | Q2 2026 | — |
| Specialties Adjusted EBITDA non-GAAP | $117.7M | Q2 2026 | — |
| Total adjusted EBITDA non-GAAP | 858.1M | Three Months Ended June 30, 2026 filing | — |
| Total segment adjusted EBITDA non-GAAP | 841.18M | Three Months Ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALB
this stock
Albemarle Corp
|
$11.04B | -33.9% | -4.4% | — | 10.5% |
|
LIN
Linde PLC
|
$241.51B | +23.4% | +3.0% | 34.9 | 1.4% |
|
AIQUF
L Air Liquide SA
|
$137.11B | +14.4% | — | — | 0.0% |
|
ECL
Ecolab Inc.
|
$86.74B | +17.8% | +2.2% | 42.1 | 1.5% |
|
SHW
Sherwin Williams Co
|
$84.53B | +8.0% | +2.1% | 32.2 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Albemarle reported third-quarter 2026 net sales of $1.6 billion, up 19%, and adjusted EBITDA of $646 million, up 186%. It cut its full-year 2026 capital expenditure forecast to $300-$350 million and raised Specialties adjusted EBITDA outlook to $350-$375 million.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALB | -5.8% | -2.0% | -46.5% | +2.8% | -33.9% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -8.4% | -0.9% | -47.0% | +3.0% | -44.5% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
